{"id":"https://openalex.org/W2107995079","doi":"https://doi.org/10.1158/1078-0432.ccr-04-0322","title":"Heteroclitic CD33 Peptide With Enhanced Anti-Acute Myeloid Leukemic Immunogenicity","display_name":"Heteroclitic CD33 Peptide With Enhanced Anti-Acute Myeloid Leukemic Immunogenicity","publication_year":2004,"publication_date":"2004-10-15","ids":{"openalex":"https://openalex.org/W2107995079","doi":"https://doi.org/10.1158/1078-0432.ccr-04-0322","mag":"2107995079","pmid":"https://pubmed.ncbi.nlm.nih.gov/15501984"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-04-0322","doi":"https://doi.org/10.1158/1078-0432.ccr-04-0322","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-04-0322","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061032029","display_name":"Jooeun E. Bae","orcid":"https://orcid.org/0000-0002-8922-9703","observed_orcids":["https://orcid.org/0000-0002-8922-9703"]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jooeun Bae","raw_affiliation_strings":["Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, Illinois","Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, Illinois, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, Illinois","institution_ids":["https://openalex.org/I1285301757"]},{"raw_affiliation_string":"Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, Illinois, USA","institution_ids":["https://openalex.org/I1285301757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103444445","display_name":"Jeffrey Martinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Martinson","raw_affiliation_strings":["Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, Illinois","institution_ids":["https://openalex.org/I1285301757"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111951054","display_name":"Hans Klingemann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hans G. Klingemann","raw_affiliation_strings":["Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, Illinois","institution_ids":["https://openalex.org/I1285301757"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1285301757"],"apc_list":null,"apc_paid":null,"fwci":0.8408,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.72402698,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"10","issue":"20","first_page":"7043","last_page":"7052"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd33","display_name":"CD33","score":0.8740000128746033},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9769999980926514},{"id":"https://openalex.org/keywords/epitope-engineering","display_name":"epitope engineering","score":0.6869999766349792},{"id":"https://openalex.org/keywords/ctl-induction","display_name":"CTL induction","score":0.6119999885559082},{"id":"https://openalex.org/keywords/hla-a-0201","display_name":"HLA-A*0201","score":0.8019999861717224},{"id":"https://openalex.org/keywords/t-cell-receptor-affinity","display_name":"T cell receptor affinity","score":0.6579999923706055},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.5559999942779541},{"id":"https://openalex.org/keywords/memory-cd8-t-cells","display_name":"memory CD8+ T cells","score":0.7139999866485596},{"id":"https://openalex.org/keywords/leukemia-immunotherapy","display_name":"leukemia immunotherapy","score":0.6029999852180481},{"id":"https://openalex.org/keywords/t-cell-clones","display_name":"T cell clones","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.7636590003967285},{"id":"https://openalex.org/C176290653","wikidata":"https://www.wikidata.org/wiki/Q21114013","display_name":"CD33","level":4,"score":0.6565795540809631},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.6449975967407227},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5506835579872131},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5501969456672668},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.49545133113861084},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.48036083579063416},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.4783039689064026},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.46005839109420776},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4344472587108612},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4130699336528778},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4031431972980499},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3846062421798706},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.35302841663360596},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2388210892677307},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.23085185885429382},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.1637592911720276},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.15320342779159546},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10694125294685364},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10222423076629639}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015214","descriptor_name":"Antigens, Differentiation, Myelomonocytic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015214","descriptor_name":"Antigens, Differentiation, Myelomonocytic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015789","descriptor_name":"HLA-A2 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D063268","descriptor_name":"Sialic Acid Binding Ig-like Lectin 3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-04-0322","doi":"https://doi.org/10.1158/1078-0432.ccr-04-0322","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-04-0322","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:15501984","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15501984","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W1504964919","https://openalex.org/W1537224150","https://openalex.org/W1546143943","https://openalex.org/W1553081674","https://openalex.org/W1588193878","https://openalex.org/W1599461328","https://openalex.org/W1599999513","https://openalex.org/W1622475644","https://openalex.org/W1943839210","https://openalex.org/W1959677146","https://openalex.org/W1964964271","https://openalex.org/W1965035133","https://openalex.org/W1969057879","https://openalex.org/W1971302107","https://openalex.org/W1976018155","https://openalex.org/W1981585216","https://openalex.org/W1983612134","https://openalex.org/W1991518988","https://openalex.org/W1998214675","https://openalex.org/W2000765914","https://openalex.org/W2001107275","https://openalex.org/W2008329899","https://openalex.org/W2016434172","https://openalex.org/W2020340397","https://openalex.org/W2020814485","https://openalex.org/W2031101268","https://openalex.org/W2039026443","https://openalex.org/W2041010325","https://openalex.org/W2051478400","https://openalex.org/W2054129665","https://openalex.org/W2063201797","https://openalex.org/W2072094250","https://openalex.org/W2076178644","https://openalex.org/W2079542677","https://openalex.org/W2090084564","https://openalex.org/W2090781503","https://openalex.org/W2099028937","https://openalex.org/W2112096110","https://openalex.org/W2123524669","https://openalex.org/W2127525056","https://openalex.org/W2128768321","https://openalex.org/W2130261432","https://openalex.org/W2131363383","https://openalex.org/W2148644851","https://openalex.org/W2159404298","https://openalex.org/W2171515055","https://openalex.org/W2171694481","https://openalex.org/W2250067628","https://openalex.org/W2294409256","https://openalex.org/W2331173884","https://openalex.org/W2402950153"],"related_works":["https://openalex.org/W2090084564","https://openalex.org/W4416343197","https://openalex.org/W2522742594","https://openalex.org/W2890901504","https://openalex.org/W2261439444","https://openalex.org/W7148797573","https://openalex.org/W2169031518","https://openalex.org/W2556156590","https://openalex.org/W2084132526","https://openalex.org/W205935876"],"abstract_inverted_index":{"The":[0,58,77,97,136],"goal":[1],"of":[2,18,87,105,109,116,164,176],"these":[3],"studies":[4],"was":[5,61,146],"to":[6,63,124,132],"engineer":[7],"a":[8,101,106,113,149,177,186],"synthetic":[9],"CD33":[10,26,83,182],"peptide":[11,60,81,94,127],"with":[12,49],"enhanced":[13,56],"immunogenicity":[14],"for":[15,39,55,189],"the":[16,50,65,125,154,162,174],"induction":[17],"acute":[19],"myeloid":[20],"leukemia":[21],"(AML)-specific":[22],"CTLs.":[23],"Eight":[24],"modified":[25,92],"peptides":[27],"YLISGDSPV,":[28],"YIGSGDSPV,":[29],"YIIIGDSPV,":[30],"YIILGDSPV,":[31],"YIISGISPV,":[32],"YIISGDLPV,":[33],"YIISGDSWV":[34],"and":[35,47,91,130,141],"YIISGDSPL":[36],"were":[37,128],"designed":[38],"increased":[40],"HLA-A2.1":[41],"or":[42,160],"T":[43],"cell":[44],"receptor":[45],"affinity":[46],"compared":[48],"native":[51,89],"CD33(65-73)":[52],"peptide,":[53],"AIISGDSPV,":[54],"immunogenicity.":[57],"YLISGDSPV":[59,126,181],"found":[62],"be":[64],"most":[66],"immunogenic":[67,179],"epitope":[68,183],"producing":[69],"highly":[70,178],"cytolytic":[71],"CTLs":[72,78],"against":[73],"AML":[74,134,142],"target":[75,133],"cells.":[76,135,168],"generated":[79],"withYLISGDSPV":[80],"showed":[82],"peptide-specificity":[84],"through":[85,148],"targeting":[86,191],"both":[88,139],"(AIISGDSPV)":[90],"(YLISGDSPV)":[93],"presenting":[95],"EBV-BLCL.":[96],"CTL":[98,155],"cultures":[99],"displayed":[100],"distinct":[102],"phenotype":[103],"consisting":[104],"high":[107],"percentage":[108,115],"activated":[110],"memory":[111],"(CD69(+)/CD45RO(+))-CD8(+)and":[112],"low":[114],"naive":[117],"(CD45RA(+)/CCR7(+))-CD8(+)cells.":[118],"In":[119,169],"addition,":[120],"T-cell":[121],"clones":[122,137,156],"specific":[123],"isolated":[129],"characterized":[131],"exhibited":[138],"HLA-A2.1-restricted":[140],"cell-specific":[143],"cytotoxicity":[144],"that":[145,184],"mediated":[147],"granule-dependent":[150],"pathway.":[151],"More":[152],"importantly,":[153],"did":[157],"not":[158],"lyse":[159],"inhibit":[161],"proliferation":[163],"normal":[165],"CD34(+)":[166],"progenitor":[167],"conclusion,":[170],"we":[171],"report":[172],"on":[173],"identification":[175],"heteroclitic":[180],"is":[185],"promising":[187],"candidate":[188],"immunotherapy":[190],"AML.":[192]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
